SHP2-interacting Transmembrane Adaptor Protein (SIT), A Novel Disulfide-linked Dimer Regulating Human T Cell Activation
Open Access
- 19 April 1999
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 189 (8) , 1181-1194
- https://doi.org/10.1084/jem.189.8.1181
Abstract
T lymphocytes express several low molecular weight transmembrane adaptor proteins that recruit src homology (SH)2 domain–containing intracellular molecules to the cell membrane via tyrosine-based signaling motifs. We describe here a novel molecule of this group termed SIT (SHP2 interacting transmembrane adaptor protein). SIT is a disulfide-linked homodimeric glycoprotein that is expressed in lymphocytes. After tyrosine phosphorylation by src and possibly syk protein tyrosine kinases SIT recruits the SH2 domain–containing tyrosine phosphatase SHP2 via an immunoreceptor tyrosine-based inhibition motif. Overexpression of SIT in Jurkat cells downmodulates T cell receptor– and phytohemagglutinin-mediated activation of the nuclear factor of activated T cells (NF-AT) by interfering with signaling processes that are probably located upstream of activation of phospholipase C. However, binding of SHP2 to SIT is not required for inhibition of NF-AT induction, suggesting that SIT not only regulates NF-AT activity but also controls NF-AT unrelated pathways of T cell activation involving SHP2.Keywords
This publication has 49 references indexed in Scilit:
- Protein–protein interactions: PDZ domain networksCurrent Biology, 1996
- Dominant-negative zeta-associated protein 70 inhibits T cell antigen receptor signaling.The Journal of Experimental Medicine, 1996
- Analytical Properties of the Nanoelectrospray Ion SourceAnalytical Chemistry, 1996
- Characterization of a novel protein‐binding module — the WW domainFEBS Letters, 1995
- Multiple kinases mediate T-cell-receptor signallingTrends in Biochemical Sciences, 1995
- An Alternative to SH2 Domains for Binding Tyrosine-Phosphorylated ProteinsScience, 1994
- SH2 domains recognize specific phosphopeptide sequencesPublished by Elsevier ,1993
- Four CD45/P56lck‐associated phosphorproteins (pp29‐pp32) undergo alterations in human T cell activationEuropean Journal of Immunology, 1992
- Stimulation of the phosphatidyl-inositol pathway can induce T-cell activationNature, 1990
- The Human T-Cell ReceptorAnnual Review of Immunology, 1984